GWAS of CRP response to statins further supports the role of APOE in statin response: A GIST consortium study

Statins are first-line treatments in the primary and secondary prevention of cardiovascular disease. Clinical studies show statins act independently of lipid-lowering mechanisms to decrease C-reactive protein (CRP), an inflammation marker. We aim to elucidate genetic loci associated with CRP statin...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Emma F. Magavern, Harshal Deshmukh, Geraldine Asselin, Elizabeth Theusch, Stella Trompet, Xiaohui Li, Raymond Noordam, Y.-D. Ida Chen, Teresa E. Seeman, Kent D. Taylor, Wendy S. Post, Jean-Claude Tardif, Dirk S. Paul, Emelia J. Benjamin, Nancy L. Heard-Costa, Ramachandran S. Vasan, Jerome I. Rotter, Ronald M. Krauss, J.Wouter Jukema, Paul M. Ridker, Patricia B. Munroe, Mark J. Caulfield, Daniel I. Chasman, Marie-Pierre Dubé, Graham A. Hitman, Helen R. Warren
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2025-02-01
Saila:	Pharmacological Research
Gaiak:	Statins C-Reactive Protein Pharmacogenetics GWAS Treatment Response Pharmacology
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S1043661824005206
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!